246 related articles for article (PubMed ID: 29432944)
1. Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence.
Liu X; Feng M; Zhang Y; Dai C; Sun B; Bao X; Deng K; Yao Y; Wang R
World Neurosurg; 2018 May; 113():e213-e221. PubMed ID: 29432944
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
4. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Cushing's syndrome after adrenal autotransplantation.
Yesil S; Demir T; Akinci B; Ozdogan O; Gazioglu N; Hatemi H
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):470-2. PubMed ID: 19885999
[TBL] [Abstract][Full Text] [Related]
6. Significant gene expression of insulin-like growth factor II and proliferating cell nuclear antigen in a rapidly growing recurrent pituitary acth-secreting adenoma.
Hashimoto K; Nagano I; Asaba K; Inoue M; Nishioka T; Takao T; Nakajo T; Mori T; Kurisaka M; Otsuka F
Horm Res; 2000; 54(4):198-202. PubMed ID: 11416238
[TBL] [Abstract][Full Text] [Related]
7. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
8. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[TBL] [Abstract][Full Text] [Related]
9. ACTH adenomas transforming their clinical expression: report of 5 cases.
Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of Cushing's disease.
Dallapiazza RF; Oldfield EH; Jane JA
Pituitary; 2015 Apr; 18(2):211-6. PubMed ID: 25724315
[TBL] [Abstract][Full Text] [Related]
11. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic Endonasal Surgery for Remission of Cushing Disease Caused by Ectopic Intracavernous Macroadenoma: Case Report and Literature Review.
Koutourousiou M; Winstead WI
World Neurosurg; 2017 Feb; 98():870.e5-870.e10. PubMed ID: 28003168
[TBL] [Abstract][Full Text] [Related]
13. The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease.
El Asmar N; Rajpal A; Selman WR; Arafah BM
J Clin Endocrinol Metab; 2018 Feb; 103(2):477-485. PubMed ID: 29244084
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of perioperative profiles of ACTH and cortisol for recurrence after transsphenoidal hypophysectomy in dogs with corticotroph adenomas.
van Rijn SJ; Hanson JM; Zierikzee D; Kooistra HS; Penning LC; Tryfonidou MA; Meij BP
J Vet Intern Med; 2015; 29(3):869-76. PubMed ID: 25959680
[TBL] [Abstract][Full Text] [Related]
15. Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: An Underestimated Entity.
Knappe UJ; Jaspers C; Buschsieweke D; Reinbold WD; Alomari A; Saeger W; Ehlenz K; Mann WA; Kann PH; Feldkamp J
Neurosurgery; 2017 Apr; 80(4):525-533. PubMed ID: 27352274
[TBL] [Abstract][Full Text] [Related]
16. Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas.
Lim JS; Lee MK; Choi E; Hong N; Il Jee S; Kim SH; Lee EJ
Endocrine; 2019 Apr; 64(1):147-156. PubMed ID: 30474823
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
[TBL] [Abstract][Full Text] [Related]
18. Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.
Stolyarov Y; Mirocha J; Mamelak AN; Ben-Shlomo A
Pituitary; 2018 Feb; 21(1):41-49. PubMed ID: 29143885
[TBL] [Abstract][Full Text] [Related]
19. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
20. Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing's disease.
Joehlin-Price AS; Hardesty DA; Arnold CA; Kirschner LS; Prevedello DM; Lehman NL
Diagn Pathol; 2017 Apr; 12(1):34. PubMed ID: 28420444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
